Cruiser Capital Advisors LLC Has $187,000 Stock Holdings in Enhabit, Inc. (NYSE:EHAB)

Cruiser Capital Advisors LLC decreased its position in Enhabit, Inc. (NYSE:EHAB) by 74.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 23,920 shares of the company’s stock after selling 69,393 shares during the quarter. Cruiser Capital Advisors LLC’s holdings in Enhabit were worth $187,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Fox Run Management L.L.C. boosted its holdings in shares of Enhabit by 290.2% in the 4th quarter. Fox Run Management L.L.C. now owns 42,237 shares of the company’s stock worth $330,000 after acquiring an additional 31,412 shares in the last quarter. Quantbot Technologies LP bought a new position in Enhabit in the 4th quarter valued at $45,000. Magnetar Financial LLC acquired a new position in Enhabit in the fourth quarter worth $171,000. Intech Investment Management LLC grew its holdings in shares of Enhabit by 27.6% during the fourth quarter. Intech Investment Management LLC now owns 15,481 shares of the company’s stock worth $121,000 after purchasing an additional 3,353 shares during the last quarter. Finally, Corient Private Wealth LLC acquired a new stake in shares of Enhabit in the fourth quarter valued at $79,000.

Enhabit Trading Down 1.1 %

Shares of NYSE EHAB opened at $8.95 on Tuesday. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The firm has a market capitalization of $451.70 million, a P/E ratio of -3.86 and a beta of 1.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The company’s 50 day simple moving average is $8.45 and its 200 day simple moving average is $7.96.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reiterated a “buy” rating on shares of Enhabit in a research report on Thursday, March 6th.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.